Ripple kopen? Dit zijn de mogelijkheden

Becton, Dickinson & Aandeel

234,00USD -1,68USD -0,71%
<
Bedrijf
Kalender
Profiel
>
<
Gerelateerd
Obligaties
>

Becton, Dickinson & Grafiek - 1 Jaar - NYSE

Taxaties voor Becton, Dickinson &

2018 2019e 2020e 2021e 2022e
Dividend 3,12 3,31 3,52 3,89 -
Dividendrendement (in %) 1,19 1,36 1,45 1,60 -
K/W-verhouding 23,73 20,72 18,51 16,63 14,27
Winst/Aandeel 11,01 11,74 13,14 14,62 17,04

Nieuws voor Becton, Dickinson & Co. (BD)

Geen nieuws beschikbaar
Meer nieuws

Analisten over Becton, Dickinson & Co. (BD)

meer analisten

Becton, Dickinson & Peer Group

Becton, Dickinson & 234,00
-0,7%
CR Bard 0,00
0,0%
Covidien 0,00
0,0%
Fresenius Medical Care 68,07
-2,4%
Fresenius 47,09
-0,6%
Gen-Probe 0,00
0,0%
STRATEC 60,90
-1,1%
Thermo Fisher Scientific 271,02
-0,2%
pagehit

Invoer toevoegen

Wat denkt u?

Profiel Becton, Dickinson & Co. (BD)naar bedrijfsprofiel

Becton, Dickinson & Co. is a global medical technology company. The company is engaged in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. The company operates through two worldwide business segments: BD Medical and BD Life Sciences. The BD Medical segment produces medical devices that are used in healthcare settings. This segment product includes needles, syringes and intravenous catheters for medication delivery; prefilled IV flush syringes; syringes and pen needles for the self-injection of insulin and other drugs used in the treatment of diabetes. The BD Life Sciences segment produces products for the safe collection and transport of diagnostic specimens, as well as instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infections and cancers. The segment also produces research and clinical tools that facilitate the study of cells, and the components of cells, to gain a better understanding of normal and disease processes. The principal products and services in the Life Sciences segment include integrated systems for specimen collection; safety-engineered blood collection products and systems; automated blood culturing and tuberculosis culturing systems; molecular testing systems for infectious diseases and women's health; microorganism identification and drug susceptibility systems; liquid-based cytology systems for cervical cancer screening; rapid diagnostic assays; microbiology laboratory automation; plated media; fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; molecular indexing and next-generation sequencing sample preparation for genomics research; clinical oncology, immunology and transplantation diagnostic/monitoring reagents and analyzers; and cell culture media supplements for biopharmaceutical manufacturing. Becton, Dickinson & Co. was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.

Aandelenkoers Becton, Dickinson & Co. (BD) in USDPush activeren

Koers 234,00 USD -1,68 -0,71 %
Tijd 22:15:13
Handelsdatum 23.05.2019
Opening 235,04
Slot 235,68
Hoogste 235,04
Laagste 232,07
52 W. Hoog 265,87
52 W. Laag 208,67
52 W. Perf.
Volume (Aantal) 199.669
Marktkap. (EUR) 58,92 Mrd
Beurs
De koers van 234,00 USD aan de beurs New York komt bij de actuele wisselkoers overeen USD/EUR met een koers van 209,27 Euro.

Naar aandeel Becton, Dickinson &

ISIN US0758871091
Indices S&P 500

Becton, Dickinson & Kerncijfers

Marktkapitalisatie in Euro 58,92 Mrd
Vrij verhandelbaar in %
Aantal Aandelen 269,73
Kasstroom/Aandeel in lokale valuta 9,30
Boekwaarde/Aandeel in lokale valuta 84,40
60 Dagen Volatiliteit 24,53
K/B verhouding

Becton, Dickinson & Historische koersen

22-5-2019 235,68 236.562
21-5-2019 233,97 374.265
20-5-2019 229,36 277.974
17-5-2019 228,36 733.491
16-5-2019 225,93 282.022

Aandelen in dezelfde sector met betere 1J Perf.